Ftse Mib
33.629,21
0,00%
DAX
17.993,69
0,00%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.222,19
0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Belite Bio Inc (BLTE) Belite Bio Inc (BLTE) Notizie

Belite Bio Inc

BLTE
43,20
0,00 (0,00%)
06 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202422:15GLOBEBelite Bio Announces Presentation at the Association for..
26/4/202401:15GLOBEBelite Bio Announces $25 Million Registered Direct Offering
22/3/202413:00GLOBEBelite Bio Announces PMDA Submission of Tinlarebant for..
12/3/202403:28GLOBEBelite Bio Announces Availability of Annual Report on Form..
12/3/202402:27GLOBEBelite Bio Reports Fourth Quarter and Full Year 2023..
06/3/202414:00GLOBEBelite Bio to Host Webcast on March 12, 2024, to Discuss..
04/3/202414:00GLOBEBelite Bio to Participate in the Leerink Partners Global..
13/2/202403:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202402:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202414:00GLOBEBelite Bio to Present at the Oppenheimer 34th Annual..
28/12/202322:16EDGAR2Form 144 - Report of proposed sale of securities
28/12/202322:15EDGAR2Form 144 - Report of proposed sale of securities
30/11/202314:00GLOBEBelite Bio to Participate in the Benchmark Company’s..
28/11/202323:16EDGAR2Form 144 - Report of proposed sale of securities
20/11/202314:00GLOBEBelite Bio to Participate in the BTIG Ophthalmology Day
16/11/202322:41EDGAR2Form 144 - Report of proposed sale of securities
16/11/202322:36EDGAR2Form 144 - Report of proposed sale of securities
14/11/202302:15GLOBEBelite Bio Reports Third Quarter 2023 Operational Highlights..
10/11/202314:35GLOBEDeutsche Bank ADR Investor Conference: Presentations Now..
07/11/202314:00GLOBEBelite Bio to Host Webcast on November 14, 2023, to Discuss..
06/11/202322:00GLOBEBelite Bio, Inc. to present at the Deutsche Bank ADR Virtual..
06/11/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202314:00GLOBEBelite Bio Presents Results from a 24-month, Phase 2 Study..
01/11/202313:35GLOBEInternational companies to host live webcasts at Deutsche..
27/10/202314:00GLOBEBelite Bio Announces Presentation at the American Academy of..
19/9/202318:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/8/202323:16EDGAR2Form 144 - Report of proposed sale of securities
31/8/202322:48EDGAR2Form 144 - Report of proposed sale of securities
09/8/202312:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202312:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: Min: Max:
Chiusura: 43,20

La tua Cronologia

NASDAQ
BLTE
Belite Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network